Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions
type: MedicalStudy
description: Randomized, Non-blind, 4-fold Crossover Study on Safety, Tolerability and Pharmacokinetics of Nifedipine After Single Oral Doses of Adalat® LA 60 mg or of a Marketed Generic Version of Nifedipine Retard 60 mg After an Overnight Fasting or Immediately After a High-fat American Breakfast in Healthy Male Volunteers
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2009-04
end date: 2009-04
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00884442
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: SocraTec R&D GmbH
study subject: Bioavailability, Therapeutical Indication Not Studied
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Bioavailability, Therapeutical Indication Not Studied

AI Analytics
type: Organization